KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Amortization of Deferred Charges (2019 - 2021)

Historic Amortization of Deferred Charges for Dynavax Technologies (DVAX) over the last 7 years, with Q4 2021 value amounting to $702000.0.

  • Dynavax Technologies' Amortization of Deferred Charges rose 701.22% to $702000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $2.7 million, marking a year-over-year increase of 597.19%. This contributed to the annual value of $2.7 million for FY2021, which is 597.19% up from last year.
  • Dynavax Technologies' Amortization of Deferred Charges amounted to $702000.0 in Q4 2021, which was up 701.22% from $687000.0 recorded in Q3 2021.
  • In the past 5 years, Dynavax Technologies' Amortization of Deferred Charges registered a high of $1.3 million during Q1 2019, and its lowest value of $627000.0 during Q2 2020.
  • Over the past 3 years, Dynavax Technologies' median Amortization of Deferred Charges value was $664500.0 (recorded in 2020), while the average stood at $721000.0.
  • Per our database at Business Quant, Dynavax Technologies' Amortization of Deferred Charges crashed by 5130.57% in 2020 and then soared by 733.65% in 2021.
  • Quarter analysis of 3 years shows Dynavax Technologies' Amortization of Deferred Charges stood at $633000.0 in 2019, then increased by 3.63% to $656000.0 in 2020, then increased by 7.01% to $702000.0 in 2021.
  • Its Amortization of Deferred Charges stands at $702000.0 for Q4 2021, versus $687000.0 for Q3 2021 and $673000.0 for Q2 2021.